RecruitingNot ApplicableNCT06993922

Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management in Patients Undergoing Craniotomy

Sponsor

Ain Shams University

Enrollment

50 participants

Start Date

May 29, 2025

Study Type

INTERVENTIONAL

Conditions

Postoperative Pain Dexmedetomidine Adjuvant Craniotomy Bupivacaine Scalp Block

Summary

This study aims to compare dexmedetomidine as an adjuvant to bupivacaine in scalp block versus bupivacaine alone for postoperative pain management in patients undergoing craniotomy.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Scalp block and Scalp block + Dexmedetomidine for people with adjuvant, bupivacaine, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.